WeLab Barcelona

Dear colleagues, collaborators, and friends, After more than 30 years of shared endeavours, in which we have grown personally and professionally, and with our emotions on the surface, we announce the closure of our company. We have travelled together through ups and downs, celebrated successes and overcome challenges as a team. We extend our deepest gratitude to each of you for your dedication, passion, and commitment to a shared goal: discovering new treatments for the benefit and well-being of patients. As we bid farewell, let's cherish the memories we've created, the bonds we've formed, and the impact we've made together. Though our paths may diverge, the spirit of collaboration and camaraderie that defines our community will always endure. We leave proud of the work accomplished and thank you for being an integral part of our journey, wishing you success in all your future challenges. With heartfelt appreciation, Welab’s team

📢 📌 New publication with the Welab's colleagues contribution! Martínez AL, Brea J, López D, Cosme N, Barro M, Monroy X, Burgueño J, Merlos M, Loza MI. In Vitro Models for Neuropathic Pain Phenotypic Screening in Brain Therapeutics. Pharmacol Res. 2024 Feb 19:107111. doi: 10.1016/j.phrs.2024.107111. Epub ahead of print. PMID: 38382648. https://lnkd.in/dfy_ZZJH Congratulations Xavier Monroy Javier Burgueño Hurtado and Manuel Merlos

📢 New publication with Welab's contribution: "Ability of biomimetic chromatography and physicochemical systems to predict the skin permeation of neutral compounds. A comparison study". Our colleague Adriana Port has contributed to this paper on the ability of five in vitro physicochemical systems to emulate the skin permeation of neutral compounds. Link to the paper: https://lnkd.in/d2GjGd6S

📢 📌 A new Chemistry Europe publication with WeLab Barcelona's scientists participation: "Towards multitargeted ligands as pain therapeutics: Dual ligands of the Cavα2δ-1 subunit of voltage-gated calcium channel and the μ-opioid receptor". https://lnkd.in/d8ZG_q53 Congrats Carmen Almansa Rosales José Luis Díaz Fernández Albert Dordal Raquel Fernandez Sandra Yeste Enrique Portillo Salido Antoni Torrens and the rest of the authors. #drugdiscovery #pain #pharmacology #medicinalchemistry #docking

📢 ❗❗❗ We are proud to announce that Welab is partner of this new EU funded project. In collaboration with 12 partners from 6 countries, Welab Barcelona is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics. This EU funded collaboration will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year time frame ensuring drug affordability and accessibility to low income countries. Link to the press release: https://lnkd.in/dD5f43zX

This week some members of the Welab's team attended the Spanish Drug Discovery Network (SDDN) meeting, held in the PRBB (Barcelona Biomedical Research Park). WeLab Barcelona was one of the partners of the event. Jose Miguel Vela (CSO & Site Manager) participated in the session "Drug Discovery projects in public – private collaborations", chaired by anabel sanz (Centre for Genomic Regulation (CRG), and the participation of Ramon Bosser from Agomab Therapeutics , Mabel Loza from Universidad de Santiago de Compostela, and Anji Miller Ph.D CLP RTTP from LifeArc. Welab also presented 4 posters: 1)https://lnkd.in/eaShPUNQ 2)https://lnkd.in/e9e4qKmi 3)https://lnkd.in/eZs9RTvt 4)https://lnkd.in/e6j8cHvt

🔔 📣 🔎 NEW WEBSITE!!! We are working in the new webpage for providing you the best information about our services. Stay tuned for new ideas and additional details that are coming. Take a sneak peek and feel free to reach out for more information. Our experts will help you in finding the best solutions for your project. https://lnkd.in/ekeXEUsq

Welab is proud to be one of the event sponsors of such interesting meeting. Don't miss the opportunity to meet your colleagues, expand your network of potential collaborators, and discuss about the tendencies and the future of drug discovery.

Still two weeks ahead to submit your poster disseminating your research, and having the chance of winning a SLAS TonyB Travel Award. Don’t miss out the opportunity! Deadline for poster submissions is 3 November ⚠️ Posters will be displayed in physical format in the Exhibition Hall of the XV Spanish Drug Discovery Network (SDDN) on 20-21 November.   Interested in presenting a poster? 🤔   Win the SLAS (Society for Laboratory Automation and Screening) Tony B. Travel Award for the most outstanding poster presented at the XV Meeting of the Spanish Drug Discovery Network.   See all the information 👇🏻 https://lnkd.in/d2yicrFP   #sddn #xvspanishdrugdiscoverynetwork #international #conference #event #posters